Predictive Scoring Model for In-Stent Restenosis Risk in Coronary Artery Disease Patients

Pan Wang1, Juan Xu1

  • 1Department of Internal Medicine, Peking University Shougang Hospital, Beijing, China.

Insights

In-stent restenosis (ISR) risk factors like high LDL-C, D-dimer, HbA1c, smoking, and poor blood pressure control were identified. A new scoring model aids in predicting ISR after coronary interventions.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Clinical Risk Prediction

Background:

  • In-stent restenosis (ISR) poses a significant clinical challenge following coronary stent implantation in patients with coronary artery disease (CAD).
  • Identifying independent risk factors for ISR is crucial for developing effective preventive strategies.
  • Predictive models can aid clinicians in managing patients at high risk for ISR.

Purpose of the Study:

  • To identify independent risk factors associated with in-stent restenosis (ISR) after percutaneous coronary intervention (PCI).
  • To develop and validate a predictive scoring model for ISR based on identified risk factors.
  • To assess the clinical utility of the developed scoring model in predicting ISR.

Main Methods:

  • A retrospective study involving 256 patients with CAD who underwent PCI between January 2017 and December 2018.
  • Logistic regression analysis was employed to determine independent predictors of ISR.
  • A scoring model was developed and its predictive performance evaluated using Receiver Operating Characteristic (ROC) curve analysis.

Main Results:

  • Elevated levels of LDL-C, D-dimer, HbA1c, and uric acid were significantly higher in the ISR group compared to the non-ISR group.
  • Independent risk factors for ISR included elevated LDL-C, D-dimer, HbA1c, post-procedural smoking, and poor blood pressure control.
  • The developed ISR scoring model demonstrated good predictive performance with an AUC of 0.8643, 85.8% sensitivity, and 73.9% specificity.

Conclusions:

  • Elevated LDL-C, D-dimer, HbA1c, post-procedural smoking, poor blood pressure control, and a family history of CAD are significant independent risk factors for ISR.
  • The developed ISR scoring model serves as a practical tool for predicting ISR risk in patients undergoing PCI.
  • This model can guide clinical management decisions to improve patient outcomes after coronary interventions.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3
Acute Coronary Syndrome III: Diagnostic studies01:30

Acute Coronary Syndrome III: Diagnostic studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Coronary Artery Disease V: Surgical Management01:27

Coronary Artery Disease V: Surgical Management

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
3
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and clinical manifestations

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
3
Acute Coronary SyndromeI: Introduction01:30

Acute Coronary SyndromeI: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
15